SPY2.00%

QQQ3.19%

Trending

Feed

News

Sentiment

Info

Historical Prices

home CoinsVITASTEM

Updated 01:20 AM UTC

VITASTEMVitaStem

Name: VitaStem(VITASTEM) Price Today, VITASTEM to USD Real-Time, Latest Discussions, Interactive Chart & News
Creator: Stocktwits

$0.0072

$0.0003

(4.34%)

Today

Mkt Cap$22,841.00

Vol71.01

News

all

press releases

No VITASTEM.X news at the moment.

Bullish/Bearish Forum Sentiment

Indicates whether most users posting on a crypto’s stream over the last 24 hours are bearish or bullish.

100

Extremely

Bearish

Neutral

Bullish

Extremely

Bearish

Bullish

N/A

Last score

N/A

1 day ago

1 week ago

1 month ago

3 months ago

6 months ago

1 year ago

Message Board Activity

Measures the total amount of chatter on a stream over the last 24 hours.

100

Extremely

Low

Normal

High

Extremely

Low

High

N/A

Last score

N/A

1 day ago

1 week ago

1 month ago

3 months ago

6 months ago

1 year ago

Discussion Diversity

Measures the number of unique accounts posting on a stream relative to the number of total messages on that stream.

100

Extremely

Low

Normal

High

Extremely

Low

High

N/A

Last score

N/A

1 day ago

1 week ago

1 month ago

3 months ago

6 months ago

1 year ago

AboutVitaSTEM — The first AI-enabled longevity project and inaugural IP-Token launched by Aubrai, VitaDAO’s decentralized scientific agent. After six months of deep research on public and proprietary single-cell RNA-seq and multi-omics datasets, our scientific research team analyzed more than 850,000 human hematopoietic stem cell transcriptomes from donors aged 23–91 (both male and female). This effort uncovered 100+ high-potential rejuvenation target genes and revealed critical drivers of decline such as RhoA hyperactivation, CD38 upregulation, and CCR9 downregulation. Rather than treating HSC aging as a single defect, Aubrai recognized it as convergent damage across interconnected systems, generating a comprehensive multi-modal, five-phase rejuvenation protocol targeting transcriptional stress, metabolic dysfunction, and epigenetic drift in parallel. The agent shortlisted target genes using insights from thousands of peer-reviewed publications and private data and also optimized experimental protocols to guide in vitro and upcoming pre-clinical testing. For the first time, human researchers and AI Agents collaborate as co-scientists in the creation of pioneering scientific IP.

Details

Fundamentals

Mkt Cap

$22,841.00

24H Volume

$71.01

7D High

$0.0084

FDV

$71,562.00

Circ Supply

3.19M

Total Supply

10M

Max Supply

10M

24H High

$0.0073

24H Low

$0.0068

Connect Stocktwits to ChatGPT

New

Real-time sentiment, trending & news in ChatGPT

Sentiment
Watchers
Trending
News

Connect Plugin

Advertisement|Remove ads.

Latest VITASTEM News

View

Top Discussions

IONQ

Quantum computing stocks - like $IONQ, $RGTI, and $QBTS - were very popular in 2025, but the sector remains pre-profit and highly speculative. Are you still bullish on quantum?

1.2K votes

CRWV

Which of these trending stocks are you most bullish on for the next 12 months - $CRWV, $LKNCY, $REPL, or $ZETA?

910 votes

MSFT

Amazon ($AMZN) and Microsoft ($MSFT) have been big winners this earnings season - which do you think posts the highest return over the next 12 months?

987 votes

Info

CategoriesBase Ecosystem, +2 more

About

VitaSTEM — The first AI-enabled longevity project and inaugural IP-Token launched by Aubrai, VitaDAO’s decentralized scientific agent. After six months of deep research on public and proprietary single-cell RNA-seq and multi-omics datasets, our scientific research team analyzed more than 850,000 human hematopoietic stem cell transcriptomes from donors aged 23–91 (both male and female). This effort uncovered 100+ high-potential rejuvenation target genes and revealed critical drivers of decline such as RhoA hyperactivation, CD38 upregulation, and CCR9 downregulation. Rather than treating HSC aging as a single defect, Aubrai recognized it as convergent damage across interconnected systems, generating a comprehensive multi-modal, five-phase rejuvenation protocol targeting transcriptional stress, metabolic dysfunction, and epigenetic drift in parallel. The agent shortlisted target genes using insights from thousands of peer-reviewed publications and private data and also optimized experimental protocols to guide in vitro and upcoming pre-clinical testing. For the first time, human researchers and AI Agents collaborate as co-scientists in the creation of pioneering scientific IP.

Advertisement|Remove ads.